Navigation Links
National Jewish, Brigham and Women's Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
Date:10/10/2007

er genetic factors are likely involved. COPD is the only leading case of death in the US that has been steadily increasing in frequency over the past decade. There is no treatment that can cure the disease and only a few measures to extend the lives of patients.

The new study will enroll smokers with and without COPD. Study participants with COPD will undergo a single study visit that will include pulmonary function tests, questionnaires about respiratory and general health, a six-minute walk test, a physical examination and a chest CT scan. After study participation, phone and mail contacts will be conducted with study participants every six months.

"The National Heart, Lung, and Blood Institute is excited to fund what will be the largest study ever of the genetics of COPD. Identifying genetic factors that contribute to this devastating disease will help us understand the biological mechanisms involved, and will ultimately lead to better treatments and improved outcomes for patients," said Elizabeth G. Nabel, MD, director of the NHLBI. The NHLBI is promoting better awareness of COPD through its public education campaign, Learn More Breathe Better. For more information, visit: http://www.learnaboutcopd.org.

A team from Johns Hopkins University, the Harvard School of Public Health (HSPH), Brigham and Women's Hospital, and the University of Colorado will provide statistical analysis.

National Jewish Medical and Research Center is known worldwide for treatment of patients with respiratory, immune and related disorders, and for groundbreaking medical research. Founded in 1899 as a nonprofit hospital, National Jewish provides the best integrated and innovative care for patients and their families; seeks to understand and find cures for the diseases we research; and educates and trains the next generation of healthcare professionals to be leaders in medicine and science. We pursue this visio
'/>"/>

SOURCE National Jewish Medical and Research Center
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
7. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
8. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
11. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... N.J., Dec. 16 Ethicon, Inc., a ... company and a worldwide leader in surgical care, ... company dedicated to designing, developing and commercializing devices ... throat (ENT), today announced a definitive merger agreement ... transaction for approximately $785 million net of estimated ...
(Date:12/16/2009)... LAKE FOREST, Ill., Dec. 16 Hospira, Inc. ... pharmaceutical and medication delivery company, today announced that it ... and full-year 2009 results and projections for 2010 on ... ,, The company will release its fourth-quarter and full-year ... market open and the conference call. ,, A live ...
(Date:12/16/2009)... 16 International, well-known,scientific experts ... GFT505 (80 mg/day),data presented as "extremely ... scientists and clinicians critically reviewed these ... of generic lipid-modifying,treatments, fenofibrate and bezafibrate, ... observed in patients with metabolic syndrome,and ...
Breaking Medicine Technology:Ethicon Announces Definitive Agreement to Acquire Acclarent 2Ethicon Announces Definitive Agreement to Acquire Acclarent 3Ethicon Announces Definitive Agreement to Acquire Acclarent 4International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3Pitt researchers harness carbon nanomaterials for drug delivery systems oxygen sensors 54668 1Pitt researchers harness carbon nanomaterials for drug delivery systems oxygen sensors 54668 2American Lung Association in Florida Joins Anti Recession Campaign by Forming Strategic Alliance With www i am anti recession com 54664 1American Lung Association in Florida Joins Anti Recession Campaign by Forming Strategic Alliance With www i am anti recession com 54664 2Study shows how to boost value of Alzheimers fighting compounds 54660 1Study shows how to boost value of Alzheimers fighting compounds 54660 2
... University graduate student has found a correlation between childhood obesity ... doctoral student in human nutrition, Manhattan, conducted research that found that ... of physical activity had greater amounts of airway narrowing after exercise. ... and inactive are having -- even at the age of 8 ...
... LONDON, Dec. 11 On December 11, 2008, ... and Drug Administration (FDA) - including the Drug ... Advisory Committee, and the Pulmonary-Allergy Drugs Advisory Committee ... risks of asthma medications containing long-acting beta-agonists (LABAs). ...
Other Medicine Technology:K-State Researcher Finds Correlation Between Childhood Obesity and Asthma 2K-State Researcher Finds Correlation Between Childhood Obesity and Asthma 3AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R) 2AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R) 3AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R) 4
(Date:12/16/2009)... If proposed health care legislation is enacted, it ... system. Approximately 18.4 million Californians and 161 million ... employer-based insurance for their health care coverage. ... legislation entail specific requirements for employer-based insurance. ... firms that currently comply with most new standards, ...
(Date:12/16/2009)... Raises Significant Funds to Benefit of Children with Autism ... Taylor, Gary Cole and Zachary Levi Join Ben Stiller ... ANGELES, Dec. 16 At its 13th annual ... individuals. Hasbro President & CEO Brian ... in recognition of his far-reaching philanthropic leadership and commitment ...
(Date:12/16/2009)... -- Immucor, Inc. (Nasdaq: BLUD ), a global ... transfusion industry, today announced that Paul D. Mintz, M.D. ... independent director, effective January 1, 2010. ,, Dr. ... medicine for more than 30 years. He is a ... of Virginia School of Medicine. He also serves as ...
(Date:12/16/2009)... The most widely used human embryonic stem cell ... justice questions that must be addressed to ensure that ... according to a University of Michigan research team. ,, ... U-M team analyzed 47 embryonic stem cell lines, including ... researchers. The scientists determined the genetic ancestry of each ...
(Date:12/16/2009)... Scientists pinpoint seven that increase susceptibility to disease ... genes associated with increased susceptibility to leprosy have ... , The researchers, who analyzed more than 10,000 ... in China, said their discovery highlights the important ... the development of leprosy. , "Though leprosy is ...
Breaking Medicine News(10 mins):Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5Health News:Immucor Appoints New Board Director 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:Leprosy Genes Identified 2
... by Avalere Health found that nearly 30% of long-term ... higher than amounts reported in widely used previous estimates. ... assisted living, a key component of long-term care.This analysis, ... that individuals and their families contributed an estimated $64 ...
... Bio-Optronics, Inc., a leader in healthcare workflow ... solution, the only comprehensive, flexible, and easy-to-use patient ... capability.The Joint Commission,s #1 patient safety goal is ... ID bands are difficult to read and time-consuming ...
... Philadelphia, 5 March 2009 The new medical subspecialty ... the way in providing technically advanced yet cost-effective care ... in the March issue of the Journal of ... the Heart Failure Society of America (HFSA) and the ...
... Connecticut,s Largest Home Care Agencies Automates and Connects ... 5 Allscripts announced today that VNA HealthCare, ... Homecare as its electronic home care system. VNA ... independent living services to 60 communities in the ...
... only specialized clinic furthers AED industry-leading commitment to ... 67th annual meeting of the American Academy of ... Inc. (Nasdaq: SLTM ) today announced ... to advance the company,s new product development, facilitate ...
... United States and Canadian Academy of Pathology (USCAP)SUNNYVALE, ... the Elekta Group and leading provider of software ... the introduction of PowerPath version 9.3, including new ... at USCAP conference in Boston, March 9-11, 2009. ...
Other Medicine News:Health News:Almost 30% of Long-Term Care is Financed Out-of-Pocket, Report Finds 2Health News:bioPoint(TM) PID Wristband Software Improves Patient Identification Accuracy and Safety 2Health News:New specialty to focus on advanced heart failure and heart transplantation 2Health News:VNA HealthCare Selects Allscripts Homecare 2Health News:VNA HealthCare Selects Allscripts Homecare 3Health News:VNA HealthCare Selects Allscripts Homecare 4Health News:VNA HealthCare Selects Allscripts Homecare 5Health News:Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center 2Health News:Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center 3Health News:Impac Software Introduces PowerPath(R) Version 9.3 AT USCAP 2Health News:Impac Software Introduces PowerPath(R) Version 9.3 AT USCAP 3
MDI will work with your facility to determine the best interim lab to fit your needs and your site....
... Type 300 ,Oblique 45, ,Type 330 ... illumination by setting the illumination between ... be ideal for use in ophthalmology ... other conventional compact microscope can; an ...
... is exactly the same as the model SP-8800 with ... separate Pachy mode. This mode has its own fixation ... all directions. It allows you to select an area ... has built-in software to calculate averages of multiple readings ...
... MedCath is the largest and most experienced ... networks in the United States. Mobile laboratories ... a daily basis, from one hospital to ... geographic area. Each mobile laboratory is fully ...
Medicine Products: